Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy

BACKGROUND: Mesenchymal stem cell (MSC)-based therapy is currently considered to be an effective treatment strategy for diabetes and hepatic disorders, such as liver cirrhosis and non-alcoholic fatty liver disease. Exosomes are important mediators of cellular connections, and increasing evidence has...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qin, Wang, Lingshu, Zhao, Ruxing, Yan, Fei, Sha, Sha, Cui, Chen, Song, Jia, Hu, Huiqing, Guo, Xinghong, Yang, Mengmeng, Cui, Yixin, Sun, Yujing, Sun, Zheng, Liu, Fuqiang, Dong, Ming, Hou, Xinguo, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278170/
https://www.ncbi.nlm.nih.gov/pubmed/32513303
http://dx.doi.org/10.1186/s13287-020-01731-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278170/
https://www.ncbi.nlm.nih.gov/pubmed/32513303
http://dx.doi.org/10.1186/s13287-020-01731-6

Ejemplares similares